Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: An item analysis of the Connor-Davidson Resilience Scale

International Clinical Psychopharmacology

Volumn 23, Issue 5, 2008, Pages 299-303

  Davidson, Jonathan ^a,f   Baldwin, David S ^d   Stein, Dan J ^e   Pedersen, Ron ^b   Ahmed, Saeed ^b   Musgnung, Jeff ^b   Benattia, Isma ^b   Rothbaum, Barbara O ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Posttraumatic stress disorder; Resilience; Venlafaxine

Indexed keywords

VENLAFAXINE; ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE;

ADAPTATION; ADULT; ARTICLE; CLINICAL TRIAL; CONNOR DAVIDSON RESILIENCE SCALE; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; EFFECT SIZE; EMOTION; EXTENDED RELEASE FORMULATION; FAITH; FEMALE; HARDINESS; HUMAN; ITEM ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERSISTENCE; PERSONALITY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RATING SCALE; RESILIENCE; SOCIAL SUPPORT; ADAPTIVE BEHAVIOR; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 54449083820     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e32830c202d     Document Type: Article

References (24)

1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (DSM-IV). 4th edtion. Washington, DC: American Psychiatric Association.
2. Ballenger JC (2004). Remission rates in patients with anxiety disorders treated with paroxetine. J Clin Psychiatry 65:1696-1707.
3. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. (1995). The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8:75-90.
4. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P (1998). Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 55:626-632.
5. Campbell-Sills L, Cohan SL, Stein MB (2006). Relationship of resilience to personality, coping, and psychiatric symptoms in young adults. Behav Res Ther 44:585-599.
6. Campbell-Sills L, Stein M (2007). Psychometric analysis and refinement of the Connor-Davidson Resilience Scale (CD-RISC): validation of a 10-item measure of resilience. J Trauma Stress 20:1019-1028. Charney DS (2004). Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry 161:195-216.
7. Connor KM, Davidson JR (2003). Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety 18:76-82.
8. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR (1999). Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. Br J Psychiatry 175:17-22.
9. Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, et al. (2006). Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized, controlled trial. Arch Gen Psychiatry 63:1158-1165.
10. Davidson JR, Payne VM, Connor KM, Foa EB, Rothbaum BO, Hertzberg MA, et al. (2005). Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder. Int Clin Psychopharmacol 20:43-48.
11. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
12. Healy D, Healy H (1998). The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing? J Affect Disord 51:313-322.
13. Hoge EA, Austin ED, Pollack MH (2007). Resilience: research evidence and conceptual considerations for posttraumatic stress disorder. Depress Anxiety 24:139-152.
14. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52:1048-1060.
15. Kim-Cohen J, Moffitt TE, Caspi A, Taylor A (2004). Genetic and environmental processes in young children's resilience and vulnerability to socioeconomic deprivation. Child Dev 75:651-668.
16. hall RD, Lewis-Fernandez R, Blanco C, Simpson HB, Lin SH, Vermes D, et al. (2007). A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety 24: 77-84.
17. Morgan CA III, Wang S, Mason J, Southwick SM, Fox P, Hazlett G, et al. (2000). Hormone profiles in humans experiencing military survival training. Biol Psychiatry 47 :891-901.
18. Rutter M (1985). Resilience in the face of adversity. Protective factors and resistance to psychiatric disorder. Br J Psychiatry 147:598-611.
19. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD (2001). Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 62:860-868.
20. Vaishnavi S, Connor K, Davidson JR (2007). An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. Psychiatr Res 152:293-297.
21. Weathers FW, Keane TM, Davidson JR (2001). Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety 13: 132-156.
22. Werner EE (1992). The children of Kauai: resiliency and recovery in adolescence and adulthood. J Adolesc Health 13:262-268.
23. Yehuda R (2002). Post-traumatic stress disorder. N Engl J Med 346:108-114.
24. Yehuda R (2004). Risk and resilience in posttraumatic stress disorder. J Clin Psychiatry 65 (Suppl 1):29-36.